Spain | Advantages and Disadvantages of Four Weight Loss Pills Available in the Market English Sur

Saxenda came first, but it wasn’t until the advent of Ozempic that obesity treatment around the world changed. A “revolution” as defined by Francisco J. Tinahones, Ibima’s scientific director and expert in the field. But fantasy turns to disappointment; Because the demand is that finding a box of this medicine in a pharmacy becomes an impossible task.

Today, We are no longer in that situation. The debate about this type of drug varies from the health side (perhaps the strongest point) to the social side; Because that doesn’t mean it’s reaching everyone. Only Ozempic has real state support in Spain and is therefore the only one somewhat more accessible, not for all bags, as a four-week treatment costs about €128.

The four drugs currently on the market work in a similar way in Spain, but they do not all have the same pharmacological principle. They generally mimic a hormone that regulates appetite and creates a feeling of fullness, and has been shown to reduce an average of 6 to 25% of body weight per year, depending on the drug and the patient.

Side effects are usually mild (nausea or vomiting) and do not always occur. In all cases, the drug is administered as a subcutaneous injection. Here are the differences between them.

Although not the most prominent of the four drugs, Saxenda was the first to reach the Spanish market four years ago.

the best: Since it was the first to be sold, it has obviously undergone the most testing so far without any contraindications or major side effects. Manufactured by Novo Nordisk.

The worst: Saxenda appears to have the lowest objective of these drugs. This means that it loses the least percentage of body weight compared to others. Specifically, about 8% of the total competition. In addition, it must be injected daily rather than weekly.

Price: Between €185 and €283 per month.

Ozempic is the second drug to be marketed in Spain. But it undoubtedly changed everything. Like Saxenda, It was initially designed to control glucose in type 2 diabetics, but it was soon realized that it caused weight loss on an unprecedented scale. Its pharmacological principle is Semaglutide, and its laboratory, Novo Nordisk, has grown exponentially since then.

The best thing: Without a doubt, the quality-price ratio. It is the cheapest of all, With just one dose per week, you can lose about 18% of your total body weight, which changes the lives of obese people.

The worst: Time has passed, but it is a drug that is very difficult to find in Spanish pharmacies, which is frustrating.

Price: 128 euros per month.

Wegovy is not similar to Ozempic; It is exactly the pharmacological principle produced by the same laboratory Novo Nordisk. Wegovy is not prescribed for type 2 diabetes, but is reserved for people who are obese.

the best: Wegovy has the same properties as Ozempic, pharmacologically speaking, and it is marketed at higher doses, resulting in a higher rate of weight loss. In addition, There is no stock problem in pharmacies.

The worst: The most negative aspect of Wegovy is that the price is not accessible to many people because it is not financed by the social security system.

Price: Between 130 and 290 euros per month.

Mounjaro, like others, works by simulating a hormone that regulates appetite and creates a feeling of fullness. What is new is In the latter case, It is a dual drug containing elements and thus more effective for weight loss. It is manufactured by Lilly and goes on sale this week, and its arrival threatens Novo Nordisk’s dominance.

the best: Previous studies have declared that the average weight loss is more than 20% of the total. By comparison, in the case of Ozempic or Wegovy; This figure is only 18. Translating this factor of more than five percent into kilos is a huge difference.

concept It was recently released and has been minimally tested. And the price is high.

Price: Between 150 and 300 euros per month.